Rottendorf Pharma GmbH News

  1. Rottendorf Pharma Is CDMO Leadership Award Winner 2025 9/28/2026

    Thanks to overwhelmingly positive customer feedback, Rottendorf Pharma has been awarded the CDMO Leadership Award 2025 in the category of "Small Molecule Dosage Form - International."

  2. Top Employer 2025: Rottendorf Pharma Receives International Award 9/28/2026

    Rottendorf Pharma has been recognized as a Top Employer 2025 in Germany. The Top Employer Institute, headquartered in Amsterdam, has assessed and certified more than 2,400 companies in 125 countries. 

  3. New Gerteis Roller Compactors: Rottendorf Pharma Invests Millions In State-Of-The-Art Technology 9/28/2026

    Rottendorf Pharma has commissioned a new dry granulation system from Swiss manufacturer Gerteis Maschinen + Processengineering AG at its Ennigerloh site.

  4. Rottendorf Pharma To Double Long-Term Manufacturing Capacity With New Campus 9/28/2026

    Rottendorf Pharma has officially begun construction of the Rottendorf Campus in Oelde, Germany, a major investment aimed at expanding manufacturing capacity for the global pharmaceutical industry.

  5. Faster Time To Market: Rottendorf Pharma And Corealis Pharma Offer Seamless OSD Development And Manufacturing 2/11/2026

    Rottendorf Pharma, a globally leading CDMO with broad oral solid dosage (OSD) development, scale-up and manufacturing capabilities across the product lifecycle, and Corealis Pharma, a North American specialist in early-stage oral solid dosage (OSD) development and Phase I and II clinical supply, have expanded their service offering through a strategic partnership.